Quarterly report [Sections 13 or 15(d)]

Consolidated Condensed Statements of Cash Flows

v3.26.3
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 26, 2026
Sep. 27, 2025
Statement of Cash Flows [Abstract]    
Cash, cash equivalents, and restricted cash, beginning of period $ 14,712 $ 8,249
Cash flows provided by (used for) operating activities:    
Net income (loss) (11,609) 359
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation 8,933 7,971
Share-based compensation 1,894 1,896
Restructuring and other charges 3,969 372
Amortization of intangibles 659 708
(Gains) losses on equity investments, net (219) (611)
Mark-to-market (gains) losses on Escrowed Shares 12,614 1,687
(Gains) losses on divestitures 18 (5,355)
Deferred taxes 56 123
Impairments and net (gain) loss on retirement of property, plant, and equipment 140 465
Changes in assets and liabilities:    
Accounts receivable (281) 162
Inventories (1,450) (9)
Accounts payable 821 (281)
Accrued compensation and benefits (207) 541
Income taxes (405) (1,196)
Other assets and liabilities (1,749) (1,423)
Total adjustments 24,793 5,050
Net cash provided by (used for) operating activities 13,184 5,409
Cash flows provided by (used for) investing activities:    
Additions to property, plant, and equipment (10,216) (11,158)
Proceeds from capital-related government incentives 215 1,018
Acquisitions, net of cash acquired (596) 0
Purchases of short-term investments (32,151) (16,401)
Maturities of short-term investments 10,767 8,236
Sales of short-term investments 11,911 2,728
Sales of equity investments 401 642
Proceeds from divestitures, net 0 6,186
Other investing (590) 494
Net cash provided by (used for) investing activities (20,259) (8,255)
Cash flows provided by (used for) financing activities:    
Issuance of commercial paper, net of issuance costs 0 3,493
Repayment of commercial paper 0 (3,493)
Payments on finance leases (951) (103)
Partner contributions 5,032 3,652
Partner distributions (14,442) (159)
Net proceeds from sales of subsidiary shares 0 922
Additions to property, plant, and equipment (1,618) (2,493)
Issuance of term debt, net of issuance costs 13,000 0
Repayments of term debt (9,000) (3,750)
Proceeds from sales of common stock through employee equity incentive plans 736 777
Net proceeds attributed to common stock and warrants issued, and Escrowed Shares 440 7,682
Net proceeds from public offering of common stock 22,617 0
Restricted stock unit withholdings (907) (286)
Other financing (146) (504)
Net cash provided by (used for) financing activities 14,761 5,738
Net increase (decrease) in cash, cash equivalents, and restricted cash 7,686 2,892
Cash, cash equivalents, and restricted cash, end of period 22,398 11,141
Non-cash supplemental disclosures:    
Acquisition of property, plant, and equipment [1] 3,215 5,068
Recognition of capital-related government incentives 1,925 6,094
Cash paid during the period for:    
Interest, net of capitalized interest 1,088 1,156
Income taxes, net of refunds $ 1,127 $ 1,939
[1] Includes $854 million with extended payment terms of greater than 90 days in the nine months ended September 26, 2026 ($1.3 billion in the nine months ended September 27, 2025).